MNPR MONOPAR THERAPEUTICS Management Changes 8-K Filing 2024 - Management Changes Monopar Therapeutics announces the retirement of CFO Kim R. Tsuchimoto and the appointment of Karthik Radhakrishnan as the new CFO.Get access to all SEC 8-K filings of the MONOPAR THERAPEUTICS